This year, we want to celebrate with you. As our way of thanking you for supporting us through the years, we want to extend these exclusive offers for your blood typing, cross matching, and other immunohematology needs.
Avail our exclusive packages for up to 80% OFF!
Please take note of our Terms & Conditions.
Our excellence and relentless finding and innovating of diagnostics solution is because of your contributions.
Thank you for being with us through these years!
Scientific Biotech Specialties, Inc. in partnership with HORIBA Medical is inviting you to attend this webinar.
Our guest speaker is Ms. Mattaneeya Pattarateerachat or Khun Pla. Currently, she is the Application Manager - Asia Pacific in Horiba Medical.
For more details...
As the world is still battling with coronavirus pandemic, SBSI is committing itself to support our healthcare workers in fighting against COVID-19 virus. With our own scientific effort, together with our healthcare workers, SBSI is sharing their knowledge and giving our services for the early detection and management of SARS-CoV-2.
According to CDC (Center for Disease Control and Prevention), some patients with COVID-19 may have signs of a hypercoagulable state and be at increased risk for venous and arterial thrombosis of large and small vessels.
Laboratory abnormalities commonly observed among hospitalized patients with COVID-19-associated coagulopathy include:
- Increased D-dimer levels
- Increased fibrin degradation products
- Prolonged prothrombin time
- Mild thrombocytopenia
With these increased in d-dimer levels and fibrin degradation, SBSI offers state-of-the-art products to measure these test and detection as seen below.
To know more about our products and services in helping to fight the continue spread of COVID-19 virus;
HYPERCOAGULABILITY AND COVID-19
© 2021-2022 Scientific Biotech Specialties, Inc. All rights reserved.